31.03.2017 • NewsBPElaine BurridgeTricoya

BP Invests in Hull Wood Acetylation Venture

UK energy giant BP will invest more than $25 million over two years in a consortium that will build and operate a wood elements acetylation plant in Hull, UK.

The new company, Tricoya Ventures UK (TVUK), has been formed in partnership with Tricoya Technologies, a subsidiary of Accsys Technology, and Medite, a producer of medium-density fiberboard (MDF). Equity stakes were not disclosed.

BP said the facility at the Saltend Chemicals Park will be the world’s first Tricoya wood elements acetylation plant, and output will be targeted for the European market. Initial capacity is expected to be 30,000 t/y. The wood chips will be treated with acetic anhydride produced by BP Chemicals at Saltend and then used to produce high-performance MDF or particle board panels.

“The co-location of the Tricoya Ventures UK pant with our acetic acid facility creates natural synergies and the foundation for a great partnership,” said Nigel Dunn, vice president of global acetyls at BP.

Paul Clegg, CEO of Accsys and chairman of Tricoya Technologies, said the new manufacturing capacity will allow it to take advantage of the substantial growing market opportunity for Tricoya, which is seeing continuous growth in demand.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.